Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bax, J. J
Right arrow Articles by Barrett, E. J
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: implications for expanded use of myocardial perfusion imaging

Jeroen J Bax

Leiden University Medical Center, The Netherlands, jbax{at}knoware.nl

Robert O Bonow

Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Diethelm Tschöepe

University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany

Silvio E Inzucchi

Yale University School of Medicine, New Haven, CT, USA

Eugene J Barrett

University of Virginia, Charlottesville, VA, USA

Patients with type 2 diabetes are at a markedly increased risk of a myocardial infarction than their non-diabetic peers. These patients often do not develop the classic warning signs of myocardial ischaemia, such as chest pain. Rather, they can display atypical symptoms or present with an acute myocardial infarction as the first indication of the presence of coronary artery disease. Current risk factor management techniques, largely based on risk factor scoring, have failed to identify this clinically important sub-population of patients, and the early diagnosis of silent myocardial ischaemia in this population would greatly aid risk stratification and subsequent therapy. Myocardial perfusion scintigraphy (MPS), using single-photon emission computed tomography (SPECT), has emerged as a specific and sensitive technique for detection of coronary artery disease in type 2 diabetic patients who have yet to develop signs or symptoms of coronary artery disease. Such abnormalities are common in this population, and are significantly associated with an increased risk of myocardial infarction or death from ischaemic heart disease. The current evidence supports MPS with SPECT as the methodology of choice for identifying silent myocardial ischaemia possibly improving cardiovascular risk stratification. Appropriate use of this technique allows earlier identification of coronary artery disease in diabetic patients.

Key Words: myocardial perfusion scintigraphy • SPECT • diabetes • coronary artery disease • silent myocardial ischaemia • cardiovascular risk stratification.

References

  • International Diabetes Federation. Figures available at www.idf.org (last accessed August 2004).
  • Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.[Abstract/Free Full Text]
  • National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health/ National Heart Lung and Blood Institute. Available at www.nhlbi.nih.gov/guidelines/cholesterol
  • Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10:S1-S10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Haffner SM; American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004;27(suppl):S68-S71.[CrossRef][Medline] [Order article via Infotrieve]
  • Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(suppl 2):S14-S21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Anand DV, Lim E., Lahiri A., Bax JJ The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J 2005;in press.
  • Geleijnse ML, Fioretti PM, Roelandt JR Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997;30:595-606.[Abstract]
  • Klocke FJ, Baird MG, Lorell BH et al. ACC/AHA/ASNC Guidelines for the clinical use of cardiac radionuclide imaging. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to Revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging. J Am Coll Cardiol 2003;42:1318-33.[Free Full Text]
  • Berman DS, Kang X., Hayes SW Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-33.[Abstract/Free Full Text]
  • Elhendy A., van Domburg RT, Bax JJ et al. Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 1998;114:1097-104.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shaw LJ, Iskandrian AE Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mansoor MR, Heller GV Gated SPECT imaging. Semin Nucl Med 1999;29:271-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • De Lorenzo A., Lima RS, Siqueira-Filho AG, Pantoja MR Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002;90:827-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wackers FJ, Young LH, Inzucchi SE et al. The Detection of Silent Myocardial Ischaemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 2004;27:1954-61.[Abstract/Free Full Text]
  • Penfornis A., Zimmermann C., Boumal D. et al. Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 2001;18:900-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mazzanti M., Marini M., Cianci G., Perna GP Stress/rest gated-SPECT imaging in asymptomatic diabetics with suspected coronary artery disease. J Nucl Cardiol 2004;11:S31.
  • Miller TD, Rajagopalan N., Hodge DO, Frye RL, Gibbons RJ Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 2004;147:890-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zellweger MJ, Hachamovitch R., Kang X. et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 2004;25:543-50.[Abstract/Free Full Text]
  • Rajagopalan N., Miller TD, Hodge DO, Frye RL, Gibbons RJ Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005;45:43-9.[Abstract/Free Full Text]
  • Vanzetto G., Halimi S., Hammoud T. et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19-26.[Abstract/Free Full Text]
  • Mieres JH, Rosman DR, Shaw LJ The role of myocardial perfusion imaging in special populations: women, diabetics, and heart failure. Semin Nucl Med 2005;35:52-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Heller GV Evaluation of the patient with diabetes mellitus and suspected coronary artery disease. Am J Med 2005;118(suppl 2):9S-14S.
  • Schinkel AF, Elhendy A., Van Domburg RT et al. Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up. Radiology 2002;225:701-06.[Abstract/Free Full Text]
  • Iskander S., Iskandrian AE Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.[Abstract/Free Full Text]
  • Taylor AJ, Merz CNB, Udelson JE Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? Proceedings of the 34th Bethesda Conference. Bethesda, Maryland, USA. October 7, 2002. J Am Coll Cardiol 2003;41:1856-917.
  • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27(suppl 1):S15-S35.[CrossRef][Medline] [Order article via Infotrieve]
  • Smith SC Jr, Greenland P.,Grundy SM AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation 2000;101:111-16.[Free Full Text]
  • Redberg RF, Greenland P., Fuster V. et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes. Circulation 2002;105:e144-52.[CrossRef][Medline] [Order article via Infotrieve]
  • Biagini E., Poldermans D., Schinkel AF et al. Long-term prognostic value of myocardial viability and ischemia during dobutamine stress echocardiography in patients with ischemic cardiomyopathy undergoing coronary revascularization. Heart 2005;91:737-42.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 5, 283-288 (2005)
DOI: 10.1177/14746514050050050801


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bax, J. J
Right arrow Articles by Barrett, E. J
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?